Dexnafenodone

This classification denotes an antidepressant agent with the molecular formula C20H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 601X8G3PCW, chemically known as 1(2h)-naphthalenone, 3,4-dihydro-2-(2-(dimethylamino)ethyl)-2-phenyl-, (s)- but generally known as dexnafenodone, which bears US NIH Compound Identifier 65834. European Medicines Agency schedules Dexnafenodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07038MIG. The term DEXNAFENODONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). DEXNAFENODONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexnafenodone under HS 29223900 and SITC 51463. As of Q4 2014, DEXNAFENODONE remains the US FDA Preferred Term for this commodity. Dexnafenodone bears US NLM identifiers UMLS ID CL386858 and NCI Concept Code C78016. SMILES: O=C1C(CCc2c1cccc2)(CCN(C)C)c1ccccc1.